JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
IRD Financials - Opus Genetics Income & Cash Flow | Ledgeburg
IRD - Opus Genetics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary IRD Stock
Financials
Financials IRD Stock
Loading...
Loading...
Income Statement
Income Statement IRD Stock
Balance Sheet
Balance Sheet IRD Stock
Cash Flow Statement
Cash Flow Statement IRD Stock
Loading...
Loading...
Home
Stocks
Opus Genetics, Inc. (IRD)
Financials
Financials of IRD
Loading...
Loading...
Loading...
Loading...
Revenue
$14.196M
Operating Income
$-38.599M
Net Income
$-49.591M
Share Count (Basic)
62.221901M
Operating Cash Flow
$-35.253M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$45.091M
Total Debt
$1.129M
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
1M
2M
3M
4M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-60M
-40M
-20M
0
20M
Annual
Quarterly
Margins
Gross
Operating
Net
-10000%
-8000%
-6000%
-4000%
-2000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-40M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-3000%
-2000%
-1000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26